Efficacy of single-dose ceftriaxone versus multiple-dose enrofloxacin in dogs with uncomplicated lower urinary tract infection: a randomised clinical trial

https://doi.org/10.17221/23/2016-VETMEDCitation:Colakoglu E.C., Haydardedeoglu A.E., Alihosseini H., Hayirli A. (2017): Efficacy of single-dose ceftriaxone versus multiple-dose enrofloxacin in dogs with uncomplicated lower urinary tract infection: a randomised clinical trial. Veterinarni Medicina, 62: 125-130.
download PDF

Dogs with uncomplicated lower urinary tract infection (LUTI) are usually treated with appropriate antibiotics for 10−14 days. In humans, a single dose of ceftriaxone is employed in the treatment of uncomplicated LUTI. The purpose of the current study was to compare the efficacy of a single dose of ceftriaxone with multiple dose (14 days) enrofloxacin administration in dogs with uncomplicated LUTI. Forty-seven non-pregnant client-owned dogs with LUTI signs were enrolled in this prospective, controlled, randomised, blinded clinical trial. The inclusion criteria were the presence of at least one type of bacteria greater than or equal to 1000 CFU/ml in each urine sample. Dogs were assigned randomly to Group ENR (n = 23) enrofloxacin treatment (5 mg/kg, s.c., s.i.d., for 14 days) and Group CEF (n = 20) ceftriaxone treatment (25 mg/kg, i.v., once). The time needed for disappearance of clinical signs ranged from 4−9 days and 1−5 days for Group ENR and Group CEF, respectively. Clinical signs significantly improved earlier in Group CEF than in Group ENR (P < 0.0001). Urine culture with less than or equal to 1000 CFU/ml was achieved on Days 17−21 after the first day of treatment in all dogs. Although a single dose of ceftriaxone can be considered as an alternative treatment to alleviate the signs of uncomplicated LUTI in dogs, its status as drug of last resort is a limiting factor for its extensive use in clinical practice.

References:
Arav-Boger Ravit (1994): Urinary Tract Infections With Low and High Colony Counts in Young Women. Archives of Internal Medicine, 154, 300-  https://doi.org/10.1001/archinte.1994.00420030104010
 
Ball KR, Rubin JE, Dowling PM (2008): Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital. Canadian Veterinary Journal 49, 985–990.
 
Bartges Joseph W (2004): Diagnosis of urinary tract infections. Veterinary Clinics of North America: Small Animal Practice, 34, 923-933  https://doi.org/10.1016/j.cvsm.2004.03.001
 
Bleidorn Jutta, Gágyor Ildikó, Kochen Michael M, Wegscheider Karl, Hummers-Pradier Eva (2010): Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial. BMC Medicine, 8, 30-  https://doi.org/10.1186/1741-7015-8-30
 
Chew DJ, DiBartola SP, Schenck P (eds) (2011): Canine and Feline Nephrology and Urology. 2nd edn. Elsevier, St Louis. 526 pp.
 
Clare S., Hartmann F.A., Jooss M., Bachar E., Wong Y.Y., Trepanier L.A., Viviano K.R. (2014): Short- and Long-Term Cure Rates of Short-Duration Trimethoprim-Sulfamethoxazole Treatment in Female Dogs with Uncomplicated Bacterial Cystitis. Journal of Veterinary Internal Medicine, 28, 818-826  https://doi.org/10.1111/jvim.12324
 
Cohn L. A., Gary A. T., Fales W. H., Madsen R. W. (2003): Trends in Fluoroquinolone Resistance of Bacteria Isolated from Canine Urinary Tracts. Journal of Veterinary Diagnostic Investigation, 15, 338-343  https://doi.org/10.1177/104063870301500406
 
Cooke Cara L., Singer Randall S., Jang Spencer S., Hirsh Dwight C. (2002): Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. Journal of the American Veterinary Medical Association, 220, 190-192  https://doi.org/10.2460/javma.2002.220.190
 
Ettinger SJ, Feldman EC (eds) (2010): Textbook of Veterinary Internal Medicine. 7th edn. Elsevier. 1965 pp.
 
Grauer GF (2009): Urinary tract infections. In: Nelson RW, Couto CG (eds): Small Animal Internal Medicine. 4th edn. Elsevier. 664–665.
 
Iravani A, Richard G A (1985): Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections.. Antimicrobial Agents and Chemotherapy, 27, 158-161  https://doi.org/10.1128/AAC.27.2.158
 
Lin Hsin-An, Yang Ya-Sung, Wang Jing-Xun, Lin Hsin-Chung, Lin De-Yu, Chiu Chun-Hsiang, Yeh Kuo-Ming, Lin Jung-Chung, Chang Feng-Yee (2016): Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. Journal of Microbiology, Immunology and Infection, 49, 237-242  https://doi.org/10.1016/j.jmii.2014.12.010
 
Ling GV, Norris CR, Franti CE, Eisele PH, Johnson DL, Ruby AL, Jang SS (2001): Interrelations of organism prevalence, specimen collection method, and host age, sex, and breed among 8,354 canine urinary tract infections (1969–1995). Journal of Veterinary Internal Medicine 15, 341–347.
 
Meyers B R, Srulevitch E S, Jacobson J, Hirschman S Z (1983): Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.. Antimicrobial Agents and Chemotherapy, 24, 812-814  https://doi.org/10.1128/AAC.24.5.812
 
Frimodt-Møller Niels (2002): Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. International Journal of Antimicrobial Agents, 19, 546-553  https://doi.org/10.1016/S0924-8579(02)00105-X
 
Nicolle Lindsay E (2002): Urinary tract infection: traditional pharmacologic therapies. The American Journal of Medicine, 113, 35-44  https://doi.org/10.1016/S0002-9343(02)01058-6
 
Park Dae Won, Peck Kyong Ran, Chung Moon Hyun, Lee Jin Seo, Park Yoon Soo, Kim Hyo Youl, Lee Mi Suk, Kim Jung Yeon, Yeom Joon Sup, Kim Min Ja (2012): Comparison of Ertapenem and Ceftriaxone Therapy for Acute Pyelonephritis and Other Complicated Urinary Tract Infections in Korean Adults: A Randomized, Double-Blind, Multicenter Trial. Journal of Korean Medical Science, 27, 476-  https://doi.org/10.3346/jkms.2012.27.5.476
 
Passmore C. A., Sherington J., Stegemann M. R. (2007): Efficacy and safety of cefovecin (Convenia?) for the treatment of urinary tract infections in dogs. Journal of Small Animal Practice, 48, 139-144  https://doi.org/10.1111/j.1748-5827.2006.00231.x
 
Polzin DJ (1999): Therapy of canine and feline urinary tract infections with enrofloxacin. Compendium on Continuing Education Practicing Veterinarian 21, 65–72.
 
REBUELTO M., ALBARELLOS G., AMBROS L., KREIL V., MONTOYA L., BONAFINE R., OTERO P., HALLU R. (2002): Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs. Journal of Veterinary Pharmacology and Therapeutics, 25, 73-76  https://doi.org/10.1046/j.1365-2885.2002.00389.x
 
RINGGER N. C., PEARSON E. G., GRONWALL R., KOHLEPP S. J. (1996): Pharmacokinetics of ceftriaxone in healthy horses. Equine Veterinary Journal, 28, 476-479  https://doi.org/10.1111/j.2042-3306.1996.tb01620.x
 
RINGGER N. C., BROWN M. P., KOHLEPP S. J., GRONWALL R. R., MERRITT K. (1998): Pharmacokinetics of ceftriaxone in neonatal foals. Equine Veterinary Journal, 30, 163-165  https://doi.org/10.1111/j.2042-3306.1998.tb04477.x
 
Rodman D. P. (): A critical review of the new oral cephalosporins. Considerations and place in therapy. Archives of Family Medicine, 3, 975-980  https://doi.org/10.1001/archfami.3.11.975
 
Seguin MA, Vaden SL, Altier C, Stone E, Levine JF (2003): Persistent urinary tract infections and reinfections in 100 dogs (1989–1999). Journal of Veterinary Internal Medicine 17, 622–631.
 
Soback S, Ziv G (1988): Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves. American Journal of Veterinary Research 49, 535–538.
 
Weese J. Scott, Blondeau Joseph M., Boothe Dawn, Breitschwerdt Edward B., Guardabassi Luca, Hillier Andrew, Lloyd David H., Papich Mark G., Rankin Shelley C., Turnidge John D., Sykes Jane E. (2011): Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. Veterinary Medicine International, 2011, 1-9  https://doi.org/10.4061/2011/263768
 
Westropp J.L., Sykes J.E., Irom S., Daniels J.B., Smith A., Keil D., Settje T., Wang Y., Chew D.J. (2012): Evaluation of the Efficacy and Safety of High Dose Short Duration Enrofloxacin Treatment Regimen for Uncomplicated Urinary Tract Infections in Dogs. Journal of Veterinary Internal Medicine, 26, 506-512  https://doi.org/10.1111/j.1939-1676.2012.00914.x
 
download PDF

© 2021 Czech Academy of Agricultural Sciences | Prohlášení o přístupnosti